Chronic heart failure and chronic obstructive pulmonary disease: one problem, one solution?

Area of Science:

• Cardiology
• Pulmonology
• Exercise Physiology

Background:

• Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are prevalent, progressive conditions with high morbidity and mortality.
• Skeletal myopathy is a common comorbidity in both CHF and COPD, significantly contributing to exercise intolerance.
• Despite advances in CHF therapies, outcomes remain suboptimal, underscoring the need for comprehensive management strategies.

Discussion:

• This editorial emphasizes the role of skeletal myopathy in exercise limitation in CHF and COPD.
• Exercise training demonstrates efficacy in improving myopathy, functional capacity, and survival in patients with CHF and COPD.
• Current clinical guidelines in developed nations recommend exercise training for both CHF and COPD.

Key Insights:

• Skeletal myopathy is a shared pathophysiological mechanism underlying exercise limitation in both CHF and COPD.
• Exercise training is a potent therapeutic intervention that benefits multiple aspects of health in these patient populations.
• Evidence supports exercise training as a guideline-recommended therapy for CHF and COPD.

Outlook:

• Addressing barriers to exercise training implementation is crucial for improving patient outcomes in CHF and COPD.
• Further research may elucidate optimal exercise protocols and integration into routine clinical practice.
• Enhanced patient adherence and healthcare provider support are essential for maximizing the benefits of exercise interventions.